Tudor Financial Inc. Acquires 237 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Tudor Financial Inc. increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,777 shares of the healthcare conglomerate’s stock after acquiring an additional 237 shares during the period. Tudor Financial Inc.’s holdings in UnitedHealth Group were worth $899,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Kathleen S. Wright Associates Inc. bought a new position in shares of UnitedHealth Group in the 3rd quarter worth $27,000. Global Wealth Strategies & Associates boosted its stake in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares in the last quarter. West Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 3rd quarter valued at $32,000. Quarry LP boosted its stake in shares of UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group in the 3rd quarter valued at $37,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $510.03 on Tuesday. The company has a market capitalization of $469.37 billion, a P/E ratio of 32.91, a P/E/G ratio of 1.39 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm’s 50 day simple moving average is $549.37 and its two-hundred day simple moving average is $563.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the business posted $5.83 earnings per share. The business’s revenue was up 6.8% compared to the same quarter last year. Research analysts expect that UnitedHealth Group Incorporated will post 29.77 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Wall Street Analyst Weigh In

Several research firms have recently commented on UNH. Morgan Stanley dropped their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Bank of America dropped their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Piper Sandler decreased their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Oppenheimer increased their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Finally, KeyCorp reiterated an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a research note on Friday. Two equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.